Your browser doesn't support javascript.
loading
Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma.
Alhalabi, Omar; Campbell, Matthew T; Xiao, Lianchun; Adriazola, Ana C; Wilson, Nathaniel R; Siefker-Radtke, Arlene O; Corn, Paul G; Zurita, Amado; Jonasch, Eric; Gao, Jianjun; Adibi, Mehrad; Kamat, Ashish M; Navai, Neema; Pisters, Louis L; Dinney, Colin; Matin, Surena F; Shah, Amishi Y.
Afiliação
  • Alhalabi O; Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Campbell MT; Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Xiao L; Department of Biostatistics, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Adriazola AC; Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Wilson NR; Department of Internal Medicine University of Texas Health Science Center at Houston Houston TX USA.
  • Siefker-Radtke AO; Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Corn PG; Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Zurita A; Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Jonasch E; Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Gao J; Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Adibi M; Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Kamat AM; Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Navai N; Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Pisters LL; Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Dinney C; Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Matin SF; Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Shah AY; Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
BJUI Compass ; 3(1): 37-44, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35475152
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: BJUI Compass Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: BJUI Compass Ano de publicação: 2022 Tipo de documento: Article